Free Trial

2seventy bio (TSVT) Short Interest Ratio & Short Volume

2seventy bio logo
$4.95 -0.01 (-0.20%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$4.96 +0.00 (+0.10%)
As of 08:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

2seventy bio Short Interest Data

2seventy bio (TSVT) has a short interest of 4.80 million shares, representing 10.18% of the float (the number of shares available for trading by the public). This marks a -6.61% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.0, indicating that it would take 6.0 days of the average trading volume of 602,846 shares to cover all short positions.

Current Short Interest
4,800,000 shares
Previous Short Interest
5,140,000 shares
Change Vs. Previous Month
-6.61%
Dollar Volume Sold Short
$12.67 million
Short Interest Ratio
6.0 Days to Cover
Last Record Date
February 28, 2025
Outstanding Shares
51,588,000 shares
Float Size
47,140,000 shares
Short Percent of Float
10.18%
Today's Trading Volume
512,434 shares
Average Trading Volume
602,846 shares
Today's Volume Vs. Average
85%
Short Selling 2seventy bio?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for 2seventy bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TSVT Short Interest Over Time

TSVT Days to Cover Over Time

TSVT Percentage of Float Shorted Over Time

Remove Ads

2seventy bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/20254,800,000 shares $12.67 million -6.6%10.2%6 $2.64
2/15/20255,140,000 shares $13.06 million -0.8%10.9%16.1 $2.54
1/31/20255,180,000 shares $13.78 million +2.0%11.0%14.9 $2.66
1/15/20255,080,000 shares $12.29 million +4.5%10.5%14.9 $2.42
12/31/20244,860,000 shares $14.29 million +3.9%10.0%14.5 $2.94
12/15/20244,680,000 shares $15.30 million -6.4%9.7%15 $3.27
11/30/20245,000,000 shares $19.95 million -2.0%10.4%16.4 $3.99
11/15/20245,100,000 shares $17.95 million -5.7%10.6%16.4 $3.52
10/31/20245,410,000 shares $23.48 million -0.2%11.2%17.6 $4.34
10/15/20245,420,000 shares $26.88 million +1.9%11.2%17.2 $4.96
9/30/20245,320,000 shares $25.11 million +3.7%11.0%14.4 $4.72
9/15/20245,130,000 shares $24.16 million -13.8%10.6%12.8 $4.71
8/31/20245,950,000 shares $28.98 million -7.0%12.3%14.7 $4.87
8/15/20246,400,000 shares $29.38 million -6.0%13.3%13.4 $4.59
7/31/20246,810,000 shares $32.14 million -6.6%14.2%13.9 $4.72
7/15/20247,290,000 shares $34.77 million +24.4%15.2%13.1 $4.77
6/30/20245,860,000 shares $22.56 million -4.6%12.2%9.6 $3.85
6/15/20246,140,000 shares $24.25 million -6.3%12.5%8.3 $3.95
5/31/20246,550,000 shares $27.71 million +0.9%13.3%6.8 $4.23
5/15/20246,490,000 shares $31.61 million -6.8%13.2%6.4 $4.87
4/30/20246,960,000 shares $31.74 million +7.4%14.6%6.3 $4.56
4/15/20246,480,000 shares $32.30 million -4.9%13.6%4.6 $4.99
3/31/20246,810,000 shares $36.43 million +29.7%14.3%4.7 $5.35
3/15/20245,250,000 shares $21 million -6.1%11.1%3.6 $4.00
2/29/20245,590,000 shares $29.07 million -3.8%11.9%3.5 $5.20
2/15/20245,810,000 shares $33.52 million -8.7%12.3%3.4 $5.77
1/31/20246,360,000 shares $32.69 million -0.6%13.6%3.3 $5.14
1/15/20246,400,000 shares $23.94 million -0.8%13.7%3.5 $3.74
12/31/20236,450,000 shares $27.54 million -24.2%13.7%3.2 $4.27
12/15/20238,510,000 shares $31.83 million -28.8%18.1%4.2 $3.74
11/30/202311,950,000 shares $21.87 million -2.9%25.4%5.8 $1.83
11/15/202312,310,000 shares $28.68 million +8.8%26.2%6.6 $2.33
10/31/202311,310,000 shares $27.60 million -23.4%25.5%6.8 $2.44
10/15/202314,770,000 shares $65.28 million -3.0%33.3%9.3 $4.42
9/30/202315,220,000 shares $59.66 million +42.2%34.4%11.2 $3.92
9/15/202310,700,000 shares $43.34 million +23.1%24.2%8.9 $4.05
8/31/20238,690,000 shares $45.10 million +22.7%19.6%8 $5.19
8/15/20237,080,000 shares $44.82 million -14.2%16.0%7.2 $6.33
7/31/20238,250,000 shares $62.62 million -7.8%18.7%9.8 $7.59
7/15/20238,950,000 shares $92.01 million +7.2%20.3%12.2 $10.28
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)

Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.

There's no time to waste. As far as I can tell, the best way to profit from this project is to make
6/30/20238,350,000 shares $84.50 million +15.8%18.9%10.7 $10.12
6/15/20237,210,000 shares $77.44 million -4.9%16.3%8.7 $10.74
5/31/20237,580,000 shares $90.28 million -1.6%17.2%9.3 $11.91
5/15/20237,700,000 shares $89.63 million -2.9%17.4%8.6 $11.64
4/30/20237,930,000 shares $75.41 million +3.3%23.0%8.6 $9.51
4/15/20237,680,000 shares $71.58 million +0.3%22.3%8.8 $9.32
3/31/20237,660,000 shares $78.13 million +13.0%23.0%9 $10.20
3/15/20236,780,000 shares $68.95 million +15.9%20.4%8.2 $10.17
2/28/20235,850,000 shares $78.92 million +17.5%17.6%8 $13.49
2/15/20234,980,000 shares $64.34 million +22.4%15.0%8.2 $12.92
1/31/20234,070,000 shares $55.35 million +8.8%12.2%7.4 $13.60
1/15/20233,740,000 shares $38.86 million +52.0%11.0%7.4 $10.39
12/30/20222,460,000 shares $23.05 million +50.0%7.2%5.2 $9.37
12/15/20221,640,000 shares $18.30 million -1.8%4.8%3.9 $11.16
11/30/20221,670,000 shares $26.17 million -4.0%4.9%4.7 $15.67
11/15/20221,740,000 shares $29.35 million -15.1%5.1%5 $16.87
10/31/20222,050,000 shares $32.55 million +9.0%5.9%5.8 $15.88
10/15/20221,880,000 shares $27.69 million -21.0%5.4%5.4 $14.73
9/30/20222,380,000 shares $34.63 million +15.0%6.8%6.7 $14.55
9/15/20222,070,000 shares $32.93 million -3.7%6.0%5.2 $15.91
8/31/20222,150,000 shares $31.67 million -10.8%6.2%4.4 $14.73
8/15/20222,410,000 shares $39.77 million -1.2%6.9%4.5 $16.50
7/31/20222,440,000 shares $35.11 million +7.0%7.0%4.4 $14.39
7/15/20222,280,000 shares $31.53 million -11.6%6.6%4.1 $13.83
6/30/20222,580,000 shares $34.06 million -5.5%7.4%4.6 $13.20
6/15/20222,730,000 shares $29.92 million +2.6%7.8%4.9 $10.96
5/31/20222,660,000 shares $32.98 million -10.7%7.6%5.4 $12.40
5/15/20222,980,000 shares $35.52 million +2.4%8.6%6.5 $11.92
4/30/20222,910,000 shares $39.17 million +10.7%12.7%6.9 $13.46
4/15/20222,630,000 shares $44.26 million +5.2%11.4%6 $16.83
3/31/20222,500,000 shares $42.65 million +28.9%11.0%5.6 $17.06
3/15/20221,940,000 shares $23.67 million -3.5%8.5%4.3 $12.20
2/28/20222,010,000 shares $29.83 million -16.6%8.9%4.4 $14.84
2/15/20222,410,000 shares $36.63 million -6.2%10.7%5.1 $15.20
1/31/20222,570,000 shares $47.98 million +31.8%11.3%5.2 $18.67
1/15/20221,950,000 shares $43.88 million -4.9%8.6%4 $22.50
12/31/20212,050,000 shares $52.54 million No Change9.0%4.2 $25.63

TSVT Short Interest - Frequently Asked Questions

What is 2seventy bio's current short interest?

Short interest is the volume of 2seventy bio shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 4,800,000 shares of TSVT short. 10.18% of 2seventy bio's shares are currently sold short. Learn More on 2seventy bio's current short interest.

What is a good short interest ratio for 2seventy bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TSVT shares currently have a short interest ratio of 6.0. Learn More on 2seventy bio's short interest ratio.

Which institutional investors are shorting 2seventy bio?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 2seventy bio: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for 2seventy bio?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.18% of 2seventy bio's floating shares are currently sold short.

Is 2seventy bio's short interest increasing or decreasing?

2seventy bio saw a decline in short interest in February. As of February 28th, there was short interest totaling 4,800,000 shares, a decline of 6.6% from the previous total of 5,140,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is 2seventy bio's float size?

2seventy bio currently has issued a total of 51,588,000 shares. Some of 2seventy bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 2seventy bio currently has a public float of 47,140,000 shares.

How does 2seventy bio's short interest compare to its competitors?

10.18% of 2seventy bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 2seventy bio: Mineralys Therapeutics, Inc. (8.18%), Nurix Therapeutics, Inc. (16.47%), Vir Biotechnology, Inc. (8.89%), Intellia Therapeutics, Inc. (26.41%), Collegium Pharmaceutical, Inc. (17.86%), Arcus Biosciences, Inc. (10.60%), Rocket Pharmaceuticals, Inc. (16.94%), Xencor, Inc. (8.46%), Xeris Biopharma Holdings, Inc. (7.47%), Phibro Animal Health Co. (4.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

What does it mean to sell short 2seventy bio stock?

Short selling TSVT is an investing strategy that aims to generate trading profit from 2seventy bio as its price is falling. TSVT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against 2seventy bio?

A short squeeze for 2seventy bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TSVT, which in turn drives the price of the stock up even further.

How often is 2seventy bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TSVT, twice per month. The most recent reporting period available is February, 28 2025.




This page (NASDAQ:TSVT) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners